Medicine


Showing 1,051-1,100 of 2,393 Results

  • Qinqin Kong

    Qinqin Kong

    Postdoctoral Scholar, General Internal Medicine

    BioI am currently a Postdoctoral Scholar in the Departments of Medicine and Health Policy at Stanford University, after earning a PhD in atmospheric science from Purdue University. My research interests lie at the intersection of climate change—particularly extreme heat—and human society. I aim to advance our understanding of the physical mechanisms, cascading impacts, and the effectiveness of potential mitigation strategies for human heat stress. My PhD research focused on how land-atmosphere interactions modulate heat stress, as well as the economic and energy impacts of increasing heat stress in the context of climate change. My postdoctoral research at Stanford evaluates the impact of heat stress on public health, especially human fertility, in low- and middle-income countries. My methodological areas of expertise include climate modeling, human biophysics modeling, and econometric modeling, which I am further developing at Stanford.

  • Krish Kowkuntla

    Krish Kowkuntla

    Affiliate, Medicine - Med/Pulmonary, Allergy & Critical Care Medicine

    BioStudent researcher focused on early cancer detection, developed low-cost biomedical device that analyzes breath-based biomarkers to identify lung cancer at its earlier stages.

  • Michael Kozal

    Michael Kozal

    Professor of Medicine (Infectious Diseases)

    BioDr. Kozal is a Professor of Medicine in the Division of Infectious Diseases and Geographic Medicine and is the Director of Operations for the Department of Medicine Clinical Research Hub. He previously served as Senior Associate Dean for Veteran Affairs at Stanford School of Medicine and Chief of Staff at VA Palo Alto Health Care System. Prior to coming to Stanford, he was a Professor of Medicine at Yale University School of Medicine and served as Associate Dean for Veteran Affairs at Yale University School of Medicine and the Chief of Staff at VA Connecticut Healthcare System.

    Dr. Kozal is a translational researcher who has focused his research career on three areas: 1) investigating the genetic determinants of HIV and HCV drug resistance, 2) the development of new molecular methods to detect viral mutations, and 3) HIV and HCV clinical trials involving new drugs and diagnostic technology. Dr. Kozal is an expert in microarray and deep sequencing technology receiving patents for his work in genotyping. Dr. Kozal previously directed the Yale HIV Clinical Trials Group and has more than 20 years of experience in running clinical trials, serving as the principal investigator or site investigator on >40 HIV and Hepatitis C trials. He has served on multiple VA and NIH/NCI review panels and was a member of the DHHS/NIH Panel on Antiretroviral Guidelines for Adults and Adolescents from 2015-2024.

    Dr. Kozal is currently serving as the overall Director of Operations for the Department of Medicine Clinical Research Hub. The key hub functions include research navigation, enhanced pre-award support for budgeting and submission strategy, streamlined contracting with research sponsors, a multisite clinical coordination center to coordinate and monitor complex studies, and a centralized digital platform for study design, data access, and analytics.

    Dr. Kozal sees patients in the Infectious Diseases Clinic and the Valley Fever Clinic in Palo Alto.

  • Fredric Kraemer

    Fredric Kraemer

    Gerald M. Reaven, MD, Professor of Endocrinology, Emeritus

    Current Research and Scholarly InterestsOur research interests are in the general area of cellular lipid and lipoprotein metabolism. The work is aimed primarily at understanding the mechanisms regulating cholesterol and triglyceride accumulation in cells. We utilize a variety of techniques from cell biology, biochemistry, and molecular biology.

  • Kristina Kudelko

    Kristina Kudelko

    Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    Current Research and Scholarly InterestsDrugs and toxins-associated pulmonary arterial hypertension, clinical outcomes research, evaluating the long-term impacts of a standardized pulmonary vascular disease fellowship training program

  • Andre Kumar MD, MEd

    Andre Kumar MD, MEd

    Clinical Associate Professor, Medicine

    BioDr. Andre Kumar is a Clinical Associate Professor in the Stanford Division of Hospital Medicine with a passion for improving patient care through Point-of-Care Ultrasound (POCUS), clinical research, and education. He earned his MD from Tulane University and completed his residency, chief residency, and a Master's in Education at Stanford University.

    Dr. Kumar has extensive experience in creating, operationalizing, and leading multi-center clinical trials, including investigations related to POCUS, COVID-19 therapeutics, procedural safety, and the long-term health consequences of infections on the heart and lungs. He continues to conduct research and teach POCUS on a local and national level, and is committed to improving the science and education that underlie the next generation of diagnostic tools. Currently, his research focuses on the impact of artificial intelligence (AI) on numerous healthcare applications, particularly for the improving the accuracy of clinician diagnosis, evidence-based management, and medical imaging.

    Dr. Kumar is also a committed educator and mentor to the next generation of physicians. His contributions to medical education have been recognized with several awards, including the Lawrence H. Mathers Award for Exceptional Commitment to Teaching (2023), the Henry J. Kaiser Foundation Award for Excellence in Clinical Teaching (2018, 2022), and the David A. Rytand Clinical Teaching Award (2018, 2022, and 2025). Dr. Kumar has contributed to the creation of educational content, including videos for the Stanford Medicine 25 series that cover various aspects of POCUS.

    Dr. Kumar has held numerous leadership positions that reflect his commitment to advancing medical education and clinical practice. He is the Director of the Rathmann Fellowship in Medical Education at Stanford University. In the School of Medicine, he serves as the Co-Director of Clinical Reasoning and Associate Course Director for the Practice of Medicine course. Dr. Kumar is also the Director of the SMART-HM Program, which focuses on faculty development. He is also the Co-Founder and Director of the SHAPE Program in the Stanford Internal Medicine Residency Program.


    List of publications: https://bit.ly/3eop95i

    ClinicalTrials.Gov registration:
    https://bit.ly/2TizOmD
    https://bit.ly/2zeNBjJ

    Media:
    https://shorturl.at/rNU46
    https://stanfordmedicine.box.com/s/jm3544zdwpihj6bstcv72x76zq9nuzbq
    https://bit.ly/33MZa0O
    https://bit.ly/3t8HE2u
    https://wb.md/2zfjY1N

  • Parth I Kumar

    Parth I Kumar

    Affiliate, Department Funds
    Fellow in Medicine - Med/Nephrology

    BioParth Kumar is a fellow in the Stanford University Nephrology Fellowship Program. Dr. Kumar holds a B.A. in Molecular and Cell Biology from UC Berkeley and an M.D. with Distinction from UCSF School of Medicine. He completed his Internal Medicine Residency at UC Irvine, where he was recognized as the Intern Teacher of the Year in 2022. Dr. Kumar's research interests span health care innovation and translational medicine, such as integrating 3D printing into clinical settings to aid patient education, evaluating novel medical devices. His past work includes the study "Evaluating the use of Radioactive Analogs of Doxorubicin for Quantifying ChemoFilter binding and Whole Body PET/MRI Biodistribution," leading to him being recognized as one of the JVIR Editor's Honorees: Distinguished Laboratory Investigations in 2022.

  • Calvin Kuo

    Calvin Kuo

    Maureen Lyles D'Ambrogio Professor

    Current Research and Scholarly InterestsWe study cancer biology, intestinal stem cells (ISC), and angiogenesis. We use primary organoid cultures of diverse tissues and tumor biopsies for immunotherapy modeling, oncogene functional screening and stem cell biology. Angiogenesis projects include blood-brain barrier regulation, stroke therapeutics and anti-angiogenic cancer therapy. ISC projects apply organoid culture and ko mice to injury-inducible vs homeostatic stem cells and symmetric division mechanisms.

  • Clair Mariam Kuriakose

    Clair Mariam Kuriakose

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioClair Kuriakose is a Physician Assistant with a clinical background in Pediatric Surgery. She joined Stanford September 2014 as the first Manager of Advanced Practice with the Center for Advanced Practice and officially transitioned to the Executive Director of Advanced Practice on August 2017. Clair is passionate about the value advanced practice providers bring to the complex and ever-changing healthcare industry and truly enjoys collaborating with the various Advanced Practice Providers in the organization to ensure the best care for our patients.

  • Allison W. Kurian, M.D., M.Sc.

    Allison W. Kurian, M.D., M.Sc.

    Professor of Medicine (Oncology) and of Epidemiology and Population Health

    Current Research and Scholarly InterestsI aim to understand cancer burden and improve treatment quality at the population level. I have a strong focus on genetic risk assessment and precision oncology. I lead epidemiologic studies of cancer risk factors, clinical trials of novel approaches to cancer risk reduction, and decision analyses of strategies to optimize cancer outcomes.

  • Lianne Kurina

    Lianne Kurina

    David and Lucile Packard Foundation Professor of Human Biology and Professor (Teaching), by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsMy recent research has focused on the physical and mental health of military service members. I'm now working with colleagues at the VA.

  • David Kurtz

    David Kurtz

    Adjunct Clinical Assistant Professor, Medicine - Oncology

    Current Research and Scholarly InterestsImplementation of noninvasive detection of malignancies in the clinic remains difficult due to both technical and clinical challenges. These include necessary improvements in sensitivity and specificity of biomarkers, as well as demonstration of clinical utility of these assays. My research focuses on technical development and implementation of assays to detect and track cancers in order to facilitate personalized disease management.

  • Ware Kuschner, M.D.

    Ware Kuschner, M.D.

    Professor of Medicine (Pulmonary, Allergy and Critical Care Medicine)

    Current Research and Scholarly InterestsOccupational and environmental lung disease; Pulmonary and systemic responses to toxicant inhalation; Indoor and outdoor air pollution health effects;

  • Wilson F Kuswanto, MD, PhD

    Wilson F Kuswanto, MD, PhD

    Adjunct Clinical Assistant Professor, Medicine - Immunology & Rheumatology

    BioDr. Kuswanto is a physician scientist, board-certified Rheumatologist and instructor in medicine at Stanford University School of Medicine. He is currently working with Garry Nolan, PhD and William Robinson MD, PhD to unravel the tissue immune responses in Rheumatologic diseases. Dr. Kuswanto obtained his medical degree at Harvard Medical School, earning his PhD in Immunology with Diane Mathis and Christophe Benoist where he uncovered the role of the immune system in tissue repair and regeneration. He later moved to Stanford University to complete his residency training and Rheumatology fellowship.

  • Paul Kwo

    Paul Kwo

    Professor of Medicine (Gastroenterology and Hepatology)

    BioDr. Kwo is currently Professor of Medicine and Director of Hepatology at the Stanford University where he joined the faculty in November 2016. Prior to joining the faculty at Stanford, he was at Indiana University for 21 years where he served as the Medical Director of Liver Transplantation. He has distinguished himself in the field of Hepatitis C therapeutics and has been the principal investigator on multiple international trials. He recently authored the ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.

  • Allison Kwong

    Allison Kwong

    Assistant Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Surgery (Abdominal Transplantation)

    Current Research and Scholarly InterestsCirrhosis, portal hypertension, liver transplantation, transplant outcomes, organ allocation, population health, quality and systems improvement

  • Uri Ladabaum

    Uri Ladabaum

    Professor of Medicine (Gastroenterology and Hepatology)

    Current Research and Scholarly InterestsGastrointestinal cancer prevention and risk management. Risk stratification. Cost-effectiveness analysis. Health services research.

  • Richard Lafayette

    Richard Lafayette

    Professor of Medicine (Nephrology)

    Current Research and Scholarly InterestsWe are continuing to grow a glomerulonephritis cohort study, including immunologic characterization. We have completed interventional studies of preeclampsia exploring the nitric oxide, endothelin system and effects on glomerular function and morphometry. We continue to recruit patients for treatment and observational studies of glomerular disease, including FSGS, membranous and particularly IgA nephropathy. We also are actively studying renal disease in systemic amyloidosis.

  • Aimmon Lago

    Aimmon Lago

    Affiliate, Biomedical Informatics (BMI) graduate training program

    BioAimmon is a healthcare and technology leader with over 20 years of experience supporting teams at Accenture, Kaiser Permanente, and Stanford Health Care. He currently serves as the Executive IT Director of Revenue Cycle and Population Health Systems at Stanford Health Care where he helps create and sustain financial value, employee engagement, and patient experience improvement.

    Aimmon holds a MS in Clinical Informatics Management from Stanford, a MS in Healthcare Administration from California State University East Bay, and a BS in Business Administration from Santa Clara University.

    He is excited about the opportunities for cost, quality, and access improvement in healthcare, and seeks to create meaningful and sustained change with the use of technology, organizational management, and financial tools.

  • Sheila Lahijani, MD, FACLP

    Sheila Lahijani, MD, FACLP

    Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
    Clinical Professor (By courtesy), Medicine - Oncology

    BioDr. Lahijani is a Clinical Professor of Medical Psychiatry and, by courtesy, Oncology, at Stanford University School of Medicine and a nationally recognized leader in psycho-oncology. With extensive training and expertise in internal medicine, psychiatry, and consultation-liaison psychiatry, she has made significant contributions to the integration of psychiatric care within oncological settings.

    Since her appointment at Stanford in 2015, Dr. Lahijani has served as the lead psychiatric oncologist at the Stanford Cancer Center, where she provides medical psychiatric consultation services and collaborates with interdisciplinary teams to enhance patient outcomes. In her capacity as Medical Director of the Stanford Cancer Center Psychosocial Oncology Program, a position she has held since 2019, she is responsible for the strategic development and implementation of comprehensive psychiatric services tailored to the unique needs of patients with cancer.

    Additionally, Dr. Lahijani serves as the Section Chief of Psycho-Oncology in the Division of Medical Psychiatry where she oversees psych-onc faculty development and leads the training of medical psychiatry fellows in psycho-oncology. She also supervises advanced practice providers while also working as an attending psychiatric oncologist to provide care for patients with complex medical and psychiatric comorbidities across all hematology and oncology units.

    Dr. Lahijani's academic credentials include her graduation from Brown Medical School, followed by the completion of a combined residency in Internal Medicine and Psychiatry at Rush University Medical Center. After completing residency, she practiced internal medicine and psychiatry with a focus on triple diagnosis (HIV, addiction medicine, mental health). She then further advanced through a Psychosomatic Medicine Fellowship at Northwestern University's Feinberg School of Medicine, during which time she received specialized training in psychiatric oncology at the Lurie Comprehensive Cancer Center and Memorial Sloan Kettering Cancer Center.

    Her clinical expertise encompasses psychopharmacology and a range of treatment modalities, including Meaning Centered Psychotherapy and Dignity Therapy. Dr. Lahijani is deeply committed to fostering relationship-centered skills and promoting provider wellness. As a faculty member of Advancing Communication Excellence at Stanford, she has led workshops designed to enhance communication competencies among faculty and staff.

    Dr. Lahijani's scholarly pursuits are at the intersection of medicine and psychiatry, with a particular emphasis on the neuropsychiatric sequelae of cancer treatment, innovations in care, and medical education. She is dedicated to the education and mentorship of trainees in Psychiatry, Internal Medicine, Hematology/Oncology, and Neurology. Through her commitment to academic excellence, Dr. Lahijani plays a pivotal role in preparing the next generation of healthcare providers to adeptly navigate the intricate and multifaceted needs of patients and their caregivers, thereby promoting a comprehensive approach to patient care.

  • Fadi George Lakkis

    Fadi George Lakkis

    Professor of Medicine (Nephrology)

    Current Research and Scholarly InterestsI study how the immune system rejects transplanted organs, with the goal of improving long-term transplant outcomes. A related area of research in my laboratory is the relationship between maternal-fetal immune interactions and reproductive success.

    https://pubmed.ncbi.nlm.nih.gov/?term=Lakkis+FG%5BAuthor%5D&sort=date

  • Rayhan A. Lal, MD

    Rayhan A. Lal, MD

    Assistant Professor of Medicine (Endocrinology) and of Pediatrics (Endocrinology)

    BioI grew up in the east bay area and have had type 1 diabetes for 30+ years. I studied electrical engineering and computer science at U.C. Berkeley (Go Bears!) with the hope of applying my knowledge to diabetes technology. The significance of clinical practice became clear to me after my siblings also developed diabetes. I am devoting my life to advancing the care of diabetes in people of all ages.

  • Ivan Lam

    Ivan Lam

    Affiliate, Medicine - Med/Family and Community Medicine

    BioIvan is a rising third-year medical student from the University of Hong Kong and a research scholar with the Stanford Center for Asian Health Research and Education. He is also a visiting scholar at Yale to study palliative medicine, global health and bioethics.

  • Vinh Lam

    Vinh Lam

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Vinh Lam is a Clinical Assistant Professor in the Department of Medicine, Division of Primary Care and Population health. He earned his MD from the David Geffen School of Medicine at UCLA and chose to stay in Los Angeles to complete his family medicine residency training at UCLA. During his training, Dr. Lam developed a strong interest in teaching and medical education through his involvement with resident education and the graduate medical education committee. He also spent 1 year as a resident informaticist where he also became very interested in informatics, medical technology, and innovative solutions to improving patient health outcomes and decreasing physician burnout. Dr. Lam enjoys caring for patients of all ages from pediatrics to geriatrics, performing office-based procedures, and prioritizing preventative care.
    Outside of medicine, Dr. Lam loves to travel with his family, dabbles in photography and videography, and enjoys attempting to recreate meals he has had while traveling with his wife.

  • Nathalie Lambrecht

    Nathalie Lambrecht

    Postdoctoral Scholar, General Internal Medicine

    Current Research and Scholarly InterestsDr. Lambrecht's research aims to address malnutrition and environmental degradation from two angles: (1) evaluating climate-resilient agricultural strategies to improve global food security, nutrition, and health, and (2) assessing approaches to promote consumption of healthy and sustainable diets.

    Climate-resilient agriculture for human health: Across various countries in Sub-Saharan Africa and South Asia, Dr. Lambrecht investigates small-scale crop and livestock agroecology as a win-win strategy to benefit human nutrition, the environment, and households’ resilience to climate change. Her current work aims to understand whether integrated crop-livestock rearing can buffer the potential negative impacts of climate shocks on children's growth in Ethiopia, Tanzania, Malawi, and Uganda. During her PhD, Dr. Lambrecht examined linkages between household livestock ownership and anemia in children in southern Ghana, investigating the hypothesis that rearing livestock could alleviate anemia by providing a source of micronutrient-rich animal-source foods, yet could also exacerbate anemia by exposing children to zoonotic pathogens. Dr. Lambrecht has also worked on a large-scale homestead food production trial in Bangladesh, examining impacts on agricultural production, and children's and women's diets and health.

    Healthy and sustainable diets: Shifting diets towards sustainable and healthy plant-forward dietary patterns is essential for mitigating climate change, reducing biodiversity loss and habitat destruction, and reducing non-communicable chronic diseases. Dr. Lambrecht is a lead researcher of the NURISHD (NURsing home and hospital food service – Implementation of Healthy and Sustainable Diets) study. This research project examines the environmental footprint and nutritional quality of food service in German healthcare institutions and evaluates the feasibility of shifting dietary patterns toward the Planetary Health Diet.

  • Curtis Langlotz

    Curtis Langlotz

    Senior Associate Vice Provost for Research, Professor of Radiology (Integrative Biomedical Imaging Informatics), of Medicine (BMIR), of Biomedical Data Science and Senior Fellow at the Stanford Institute for Human-Centered AI

    Current Research and Scholarly InterestsMy laboratory develops machine learning methods to help physicians detect disease and eliminate diagnostic errors. My laboratory is developing neural network systems that detect and classify disease on medical images. We also develop natural language processing methods that use the narrative radiology report for contrastive learning and other multi-modal methods that improve the accuracy and capability of machine learning systems.

  • Benjamin Laniakea

    Benjamin Laniakea

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    BioDr. Benji Laniakea serves as the chief of the Stanford LGBTQ+ Adult Clinical Program, which offers comprehensive and tailored healthcare for the LGBTQ+ patient population for patients of all ages, sexualities, and gender identities. They also serve as the theme lead for the Sex, Gender, Sexuality, and Sexual Function curriculum at the Stanford School of Medicine for which they received the Arthur L. Bloomfield Award.